View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
May 23, 2021

North America’s medical devices industry saw a rise of 5.43% in deal activity during April 2021

North America’s medical devices industry saw a rise of 5.43% in deal activity during April 2021, when compared with the last 12-month average, led by $5bn acquisition of CA Healthcare Acquisition and LumiraDx, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 97 medical devices industry deals worth $9.6bn were announced for the region in April 2021, against the 12-month average of 92 deals.

Of all the deal types, venture financing saw most activity in April 2021 with 60 transactions, representing a 61.9% share for the region.

In second place was M&A with 25 deals, followed by private equity deals with 12 transactions, respectively capturing a 25.8% and 12.4% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $7.41bn, while venture financing and private equity deals totalled $1.43bn and $727.8m, respectively.

North America medical devices industry deals in April 2021: Top deals

The top five medical devices deals accounted for 79.7% of the overall value during April 2021.

The combined value of the top five medical devices deals stood at $7.62bn, against the overall value of $9.6bn recorded for the month.

The top five medical devices industry deals of April 2021 tracked by GlobalData were:

1) The $5bn merger of CA Healthcare Acquisition and LumiraDx

2) The $1.8bn acquisition deal with Luminex by DiaSorin

3) The Carlyle Group’s $435m private equity deal with Unchained Labs

4) The $200m acquisition of Genosity by InVitae

5) Mountain Crest AcquisitionII’s acquisition of Better Therapeutics for $187m.

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network